Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Quest Partners LLC

Quest Partners LLC raised its position in Addus HomeCare Co. (NASDAQ:ADUS) by 4,087.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,263 shares of the company’s stock after purchasing an additional 10,994 shares during the quarter. Quest Partners LLC owned about 0.06% of Addus HomeCare worth $1,498,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the company. Texas Permanent School Fund Corp increased its stake in shares of Addus HomeCare by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after acquiring an additional 82 shares during the period. Arizona State Retirement System increased its stake in shares of Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the period. Inspire Investing LLC increased its stake in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock valued at $414,000 after acquiring an additional 100 shares during the period. Finally, New York State Teachers Retirement System increased its stake in shares of Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock valued at $1,132,000 after acquiring an additional 100 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. TD Cowen raised their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. This trade represents a 11.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $120.20 on Wednesday. The company has a 50 day moving average price of $128.68 and a 200 day moving average price of $122.89. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of 27.51, a P/E/G ratio of 2.09 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same quarter last year, the business posted $1.03 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Equities analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.